[RCUS] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[RCUS] Arcus Biosciences, Inc.
Announcement Date
05-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 20.43%
YoY- -106.73%
Quarter Report
RCUS's Result
RCUS's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 1,750 1,750 9,750 1,750 1,750 1,750 1,562 7.87%
PBT -45,074 -27,753 -16,598 -22,352 -28,090 -17,670 -12,295 137.94%
Tax -131 -482 -856 -1,254 -1,482 -1,534 -2,459 -85.86%
NP -45,074 -27,753 -16,598 -22,352 -28,090 -17,670 -12,295 137.94%
Tax Rate - - - - - - - -
Total Cost 46,824 29,503 26,348 24,102 29,840 19,420 13,857 125.34%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -2,575.66 -1,585.89 -170.24 -1,277.26 -1,605.14 -1,009.71 -787.13 120.56%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.93 -0.63 -0.38 -0.51 -0.64 -0.41 -0.28 122.77%
EPS Diluted -0.93 -0.63 -0.38 -0.51 -0.64 -0.41 -0.28 122.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.